Perflubron decreases inflammatory cytokine production by human alveolar macrophages

被引:72
作者
Thomassen, MJ [1 ]
Buhrow, LT [1 ]
Wiedemann, HP [1 ]
机构
[1] CLEVELAND CLIN FDN, DEPT IMMUNOL, CLEVELAND, OH 44195 USA
关键词
perflubron; tumor necrosis factor; interleukin-1; interleukin; 6; human alveolar macrophages; endotoxin; adult respiratory distress syndrome; cytokine; bronchoalveolar lavage; antiinflammatory; partial liquid ventilation;
D O I
10.1097/00003246-199712000-00023
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine whether inflammatory cytokine production by stimulated human alveolar macrophages is affected by perflubron exposure. Design: Controlled laboratory investigation of alveolar macrophage function in vitro, Setting: Research laboratory, Subjects: Cultured alveolar macrophages obtained by bronchoalveolar lavage from eleven normal volunteers. interventions: Endotoxin stimulated alveolar macrophages were treated with perflubron. Measurements and Main Results: Alveolar macrophages were stimulated for 1 hr with lipopolysaccharide and then treated with perflubron for 23 hrs. Cell free supernatants were collected and cytokines were assayed by enzyme-linked immunosorbent assay. Tumor necrosis factor-alpha, interleukin-l, and interleukin-g were stimulated by lipopolysaccharide (endotoxin) and all of these cytokines were significantly (p <.05) inhibited by perflubron. Cell viability was not affected by perflubron, Basal cytokine concentrations from unstimulated alveolar macrophages were not altered by perflubron. Conclusions: Exposure of stimulated human alveolar macrophages to perflubron in vitro decreases cytokine production. This observation suggests that perflubron may have anti-inflammatory activity.
引用
收藏
页码:2045 / 2047
页数:3
相关论文
共 26 条
[1]   Surfactant suppresses NF-kappa B activation in human monocytic cells [J].
Antal, JM ;
Divis, LT ;
Erzurum, SC ;
Wiedemann, HP ;
Thomassen, MJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (04) :374-379
[2]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]  
BARTLETT R, 1997, CRIT CARE MED, V25, pA35
[4]  
BORDEN EC, 1994, J LAB CLIN MED, V123, P824
[5]  
Demling R H, 1993, New Horiz, V1, P388
[6]   Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCl, and reduces viscosity of cystic fibrosis sputum [J].
Ghio, AJ ;
Marshall, BC ;
Diaz, JL ;
Hasegawa, T ;
Samuelson, W ;
Povia, D ;
Kennedy, TP ;
Piantadosi, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :783-788
[7]   IMPROVEMENT OF GAS-EXCHANGE, PULMONARY-FUNCTION, AND LUNG INJURY WITH PARTIAL LIQUID VENTILATION - A STUDY MODEL IN A SETTING OF SEVERE RESPIRATORY-FAILURE [J].
HIRSCHL, RB ;
TOOLEY, R ;
PARENT, AC ;
JOHNSON, K ;
BARTLETT, RH .
CHEST, 1995, 108 (02) :500-508
[8]   TUMOR-NECROSIS-FACTOR LEVELS IN SERUM AND BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
HYERS, TM ;
TRICOMI, SM ;
DETTENMEIER, PA ;
FOWLER, AA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02) :268-271
[9]   ELEVATED INTERLEUKIN-1 RELEASE BY HUMAN ALVEOLAR MACROPHAGES DURING THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
JACOBS, RF ;
TABOR, DR ;
BURKS, AW ;
CAMPBELL, GD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (06) :1686-1692
[10]   CYTOKINES OF THE LUNG [J].
KELLEY, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03) :765-788